Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01111_DB01337_nanopub.RAli18iMW1axL46Sm9rzRPiiua0YKOwXYJGH3godogwaE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01111_DB01337 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01111_DB01337 label "DDI between Colistimethate and Pancuronium - Colistimethate may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. If possible, avoid concomitant use of these products. Monitor for deeper, prolonged neuromuscular-blocking effects (respiratory paralysis) in patients receiving concomitant neuromuscular-blocking agents and polymyxin antibiotics (e.g., colistimethate, polymyxin B). [drugbank_resource:DB01111_DB01337]" assertion.
- drugbank_resource:DB01111_DB01337 identifier "drugbank_resource:DB01111_DB01337" assertion.
- drugbank_resource:DB01111_DB01337 title "DDI between Colistimethate and Pancuronium - Colistimethate may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. If possible, avoid concomitant use of these products. Monitor for deeper, prolonged neuromuscular-blocking effects (respiratory paralysis) in patients receiving concomitant neuromuscular-blocking agents and polymyxin antibiotics (e.g., colistimethate, polymyxin B)." assertion.
- drugbank:DB01111 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01111_DB01337 assertion.
- drugbank:DB01337 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01111_DB01337 assertion.